Groowe Groowe / Newsroom / ANAB
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

ANAB News

AnaptysBio, Inc. Common Stock

Anaptys to Provide Overview of ANB033, a CD122 antagonist, at Virtual Investor Event on Tuesday, Oct. 14

globenewswire.com
ANAB

Anaptys Announces Intent to Separate Biopharma Operations from Substantial Royalty Assets by Year-end 2026

globenewswire.com
ANAB